GLP-1 drugs Archives - Inside WashU Medicine

The surprising risks of quitting Ozempic (Links to an external site)

November 10, 2026November 10, 2026

National Geographic

GLP-1 drugs linked to lower cardiovascular risk in people with serious mental illness

October 29, 2026October 29, 2026

Researchers in the Cardiovascular Division found that GLP-1 medications including semaglutide and tirzepatide were linked with lower risks of heart attack, heart failure and death among adults with serious mental illness, type 2 diabetes and obesity.